Incidence and clinical presentation of moderate to severe Graves' orbitopathy in a Danish population before and after iodine fortification of salt

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 7, 2012, Pages 2325-2332

  Laurberg, Peter ^a   Berman, Dalia C ^a   Pedersen, Inge Bülow ^a   Andersen, Stig ^a   Carlé, Allan ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DENMARK; DIET SUPPLEMENTATION; DISEASE SEVERITY; ENDOCRINE OPHTHALMOPATHY; FEMALE; GRAVES DISEASE; HUMAN; INCIDENCE; IODINATION; MAJOR CLINICAL STUDY; MALE; POPULATION RISK; PRIORITY JOURNAL; PROSPECTIVE STUDY; SALT INTAKE; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; CHILD; DENMARK; FEMALE; GRAVES DISEASE; GRAVES OPHTHALMOPATHY; HUMANS; INCIDENCE; IODINE; MALE; MIDDLE AGED; PHENOTYPE; POPULATION; SEVERITY OF ILLNESS INDEX; SODIUM CHLORIDE, DIETARY; TIME FACTORS; YOUNG ADULT;

EID: 84863570065     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-1275     Document Type: Article

References (34)

1. Bahn RS 2010 Graves' ophthalmopathy. N Engl J Med 362:726-738
2. Wiersinga WM 2011 Autoimmunity in Graves' ophthalmopathy: the result of an unfortunate marriage between TSH receptors and IGF-1 receptors? J Clin Endocrinol Metab 96:2386-2394
3. Abraham-Nordling M, Byström K, Töring O, Lantz M, Berg G, Calissendorff J, Nyström HF, Jansson S, Jörneskog G, Karlsson FA, Nyström E, Ohrling H, Orn T, Hallengren B, Wallin G 2011 Incidence of hyperthyroidism in Sweden. Eur J Endocrinol 165:899-905
4. Bartalena L, Baldeschi L, Dickinson A, Eckstein A, Kendall-Taylor P, Marcocci C, Mourits M, Perros P, Boboridis K, Boschi A, Currò N, Daumerie C, Kahaly GJ, Krassas GE, Lane CM, Lazarus JH, Marinò M, Nardi M, Neoh C, Orgiazzi J, Pearce S, Pinchera A, Pitz S, Salvi M, Sivelli P, Stahl M, von Arx G, Wiersinga WM 2008 Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol 158:273-285 (Pubitemid 351404990)
5. Wiersinga WM, Prummel MF, Terwee CB 2004 Effects of Graves'ophthalmopathy on quality of life. J Endocrinol Invest 27:259-264
6. Ponto KA, Hommel G, Pitz S, Elflein H, Pfeiffer N, Kahaly GJ 2011 Quality of life in a German Graves' orbitopathy population. Am J Ophthalmol 152:483-490.e1
7. Wiersinga WM, Bartalena L 2002 Epidemiology and prevention of Graves' ophthalmopathy. Thyroid 12:855-860 (Pubitemid 35332989)
8. Andersson M, de Benoist B, Rogers L 2010 Epidemiology of iodine deficiency: salt iodisation and iodine status. Best Pract Res Clin Endocrinol Metab 24:1-11
9. Laurberg P, Jørgensen T, Perrild H, Ovesen L, Knudsen N, Pedersen IB, Rasmussen LB, Carlé A, Vejbjerg P 2006 The Danish investigation on iodine intake and thyroid disease, DanThyr: status and perspectives. Eur J Endocrinol 155:219-228 (Pubitemid 44269438)
10. Carlé A, Pedersen IB, Knudsen N, Perrild H, Ovesen L, Rasmussen LB, Laurberg P 2011 Epidemiology of subtypes of hyperthyroidism in Denmark: a population-based study. Eur J Endocrinol 164:801-809
11. Werner SC 1969 Classification of the eye changes of Graves' disease. J Clin Endocrinol Metab 29:982-984
12. Donaldson SS, Bagshaw MA, Kriss JP 1973 Supervoltage orbital radiotherapy for Graves' ophthalmopathy. J Clin Endocrinol Metab 37:276-285
13. Werner SC 1977 Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. J Clin Endocrinol Metab 44:203-204 (Pubitemid 8030805)
14. Bahn RS, Gorman CA 1987 Choice of therapy and criteria for assessing treatment outcome in thyroid-associated ophthalmopathy. Endocrinol Metab Clin North Am 16:391-407 (Pubitemid 18088083)
15. Mourits MP, Koornneef L, Wiersinga WM, Prummel MF, Berghout A, van der Gaag R 1989 Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. Br J Ophthalmol 73:639-644 (Pubitemid 19202075)
16. European Thyroid Association, Japanese Thyroid Association (Asia-Oceania Thyroid Association), Latin-American Thyroid Association, American Thyroid Association 1992 Classification of eye changes of Graves' disease. Thyroid 2:235-236
17. Bartley GB 1995 Evolution of classification systems for Graves'ophthalmopathy. Ophthal Plast Reconstr Surg 11:229-237
18. Dolman PJ, Rootman J 2006 VISA classification for Graves' orbitopathy. Ophthal Plast Reconstr Surg 22:319-324
19. Haggerty H, Richardson S, Mitchell KW, Dickinson AJ 2005 A modified method for measuring uniocular fields of fixation: reliability in healthy subjects and in patients with Graves' orbitopathy. Arch Ophthalmol 123:356-362 (Pubitemid 41007580)
20. Rowe FJ, Hanif S 2011 Uniocular and binocular fields of rotation measures: Octopus versus Goldmann. Graefes Arch Clin Exp Ophthalmol 249:909-919
21. Pedersen IB, Laurberg P, Arnfred T, Knudsen N, Jørgensen T, Perrild H, Ovesen L 2002 Surveillance of disease frequency in a population by linkage to diagnostic laboratory databases. A system for monitoring the incidences of hyper- and hypothyroidism as part of the Danish iodine supplementation program. Comput Methods Programs Biomed 67:209-216 (Pubitemid 34195449)
22. Rothman KJ, Greenland S, Lash TL 2008 Modern epidemiology. 3rd ed. Philadelphia, PA: Lippincott Williams, Wilkins
23. Kirkwood BR, Sterne JA 2003 Essential medical statistics. 2nd ed. Oxford, UK: Blackwell
24. Stan MN, Bahn RS 2010 Risk factors for development or deterioration of Graves' ophthalmopathy. Thyroid 20:777-783
25. Bartley GB 1994 The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota. Trans Am Ophthalmol Soc 92:477-588
26. Bartley GB, Fatourechi V, Kadrmas EF, Jacobsen SJ, Ilstrup DM, Garrity JA, Gorman CA 1995 The incidence of Graves' ophthalmopathy in Olmsted County, Minnesota. Am J Ophthalmol 120:511-517
27. Bartley GB, Fatourechi V, Kadrmas EF, Jacobsen SJ, Ilstrup DM, Garrity JA, Gorman CA 1996 Clinical features of Graves' ophthalmopathy in an incidence cohort. Am J Ophthalmol 121:284-290 (Pubitemid 26085092)
28. Bartley GB, Fatourechi V, Kadrmas EF, Jacobsen SJ, Ilstrup DM, Garrity JA, Gorman CA 1996 Chronology of Graves' ophthalmopathy in an incidence cohort. Am J Ophthalmol 121:426-434 (Pubitemid 26113285)
29. Wiersinga WM, Smit T, van der Gaag R, Koornneef L 1988 Temporal relationship between onset of Graves' ophthalmopathy and onset of thyroidal Graves' disease. J Endocrinol Invest 11:615-619
30. Perros P, Crombie AL, Matthews JN, Kendall-Taylor P 1993 Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinic. Clin Endocrinol (Oxf) 38:367-372 (Pubitemid 23105068)
31. Marcocci C, Bartalena L, Bogazzi F, Panicucci M, Pinchera A 1989 Studies on the occurrence of ophthalmopathy in Graves' disease. Acta Endocrinol 120:473-478 (Pubitemid 19106348)
32. Carlé A, Laurberg P, Pedersen IB, Knudsen N, Perrild H, Ovesen L, Rasmussen LB, Jørgensen T 2009 Mainly the younger hypothyroid patients are referred to hospital - evidence for referral bias. J Clin Epidemiol 62:446-451
33. Bahn RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, Laurberg P, McDougall IR, Montori VM, Rivkees SA, Ross DS, Sosa JA, Stan MN 2011 Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid 21:593-646
34. Rasmussen LB, Carlé A, Jørgensen T, Knudsen N, Laurberg P, Pedersen IB, Perrild H, Vejbjerg P, Ovesen L 2008 Iodine intake before and after mandatory iodization in Denmark: results from the Danish Investigation of Iodine Intake and Thyroid Diseases (DanThyr) study. Br J Nutr 100:166-173